U.S. Psychedelic Drugs Market Popular Trends & Technological Advancements To Watch Out For Near Future – Global Industry Analysis 2028||Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS, usonainstitute.org, Develco pharma schweiz ag , Doughlas pharmaceuticals limited, NeuroRX, Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS
U.S. Psychedelic Drugs Market 2021 document provides the most up-to-date market insight and analysis. The key players of the market are making moves like product launches, joint ventures, developments, mergers, and acquisitions which is affecting the market and industry as a whole and also affecting the sales, import, export, revenue, and CAGR values. Furthermore, this report attempts to determine the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. This market report utilizes expertise solutions and potential capabilities that help to grow business and thrive in the market. This industry analysis report has been prepared based on a detailed market analysis with inputs from industry experts. It includes historic data, present market trends, environment, technological innovation, upcoming technologies, and the technical progress in the related industry.
U.S. Psychedelic Drugs Market is forecasted to grow at 16.3% with factors such as increasing prevalence of depression and mental disorders driving the growth of the U.S. psychedelic drugs market
U.S. psychedelic drugs market has shown an increasing prevalence of depression and mental disorders which are increasing demand of psychedelic drugs. Although, regulations imposed on psychedelic drugs restricts the growth of the market.
Get Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) at (AVAIL UP-TO 30% OFF) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-psychedelic-drugs-market
Some of the Key Players/Manufacturers Involved in the Market are:
- Johnson & Johnson Services, Inc.
- Jazz Pharmaceuticals, Inc.
- Celon Pharma SA
- Develco pharma schweiz ag
- Doughlas pharmaceuticals limited
- NeuroRX, Inc.
- Hikma Pharmaceuticals PLC
- Amneal Pharmaceuticals, LLC.
- AVADEL PHARMACEUTICALS, PLC
U.S. Psychedelic Drugs Market, By Source (Synthetic, Natural), Type (Dissociatives, Empathogens, Serotonergic (Classical Psychedelic Drugs) ), Application (Narcolepsy, Treatment-Resistant Depression, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder, Others), Route of Administration (Oral, Intranasal, Parenteral, Others), Drugs (Gamma Hydroxybutyric Acid (GHB), Ketamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), Psilocybin), End User (Hospitals, Speciality Clinic, Research Organization, Others), Distribution Channel(Hospital Pharmacy, Compounding Pharmacy, Others) – Industry Trends and Forecast to 2027
Market Analysis and Insights: U.S. Psychedelic Drugs Market
Psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth.
The psychedelic drugs are used to enhance or change sensory perceptions, energy levels, thought processes, and to facilitate spiritual experiences. Psychedelic drugs can be categorized into dissociative drugs (such as PCP), empathogens and serotonergic (classic hallucinogens) (such as LSD). These drugs are used in the treatment of major depressive disorder, treatment-resistant depression, panic disorder, post-traumatic stress disorder, and opiate addiction among others. Chemical substances that are used in the psychedelic drugs are a group of LSD, and plants. Psychedelic are sourced from synthetic process (human-made) and plants or mushrooms. Psychedelic drugs has various street names such as LSD which are also known as acid, blotter, dots, sugar, trips and window pane; Ketamine are also known as vitamin K, bump, green, K/Special K, purple and super acid; PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.
Get Complete Details with TOC For Free @ https://www.databridgemarketresearch.com/toc/?dbmr=us-psychedelic-drugs-market
List of Figure:
FIGURE 1 U.S. PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 2 U.S. PSYCHEDELIC DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 U.S. PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS
FIGURE 4 U.S. PSYCHEDELIC DRUGS MARKET : COUNTRY VS REGIONAL MARKET ANALYSIS
FIGURE 5 U.S. PSYCHEDELIC DRUGS MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 8 U.S. PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 9 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS ARE DRIVING THE U.S. PSYCHEDELIC DRUGS MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 10 SYNTHETIC IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. PSYCHEDELIC DRUGS MARKET IN 2020 & 2027
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF U.S. PSYCHEDELIC DRUGS MARKET
FIGURE 12 MENTAL ILLNESS AMONG THE U.S. ADULTS IN 2018, BY DEMOGRAPHIC GROUP
FIGURE 13 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS IN 2018, BY DEMOGRAPHIC GROUP:
FIGURE 14 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS IN 2018, BY GENDER :
FIGURE 15 PREVALENCE OF DEPRESSIVE DISORDERS IN 2017
FIGURE 16 PREVALENCE OF ANXIETY DISORDERS IN 2017
FIGURE 17 PREVALENCE OF BIPOLAR DISORDER IN 2017
FIGURE 18 THE RIPPLE EFFECT OF MENTAL ILLNESS
FIGURE 19 MENTAL AND SUBSTANCE USE DISORDERS GLOBALLY IN 2017
FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE IN WORLD IN 2017
FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS IN THE U.S.
Table Of Content::
2 MARKET SEGMENTATION
2.1 GEOGRAPHICAL SCOPE
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCTS LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 VENDOR SHARE ANALYSIS
2.9 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRACTICING PSYCHIATRISTS
4.2 PIPELINE PRODUCTS
6 MARKET OVERVIEW
6.1.1 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
6.1.2 INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
6.1.3 RISING AWARENESS TOWARDS MENTAL HEALTH
6.2.1 STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
6.2.2 HIGH COST OF PSYCHEDELIC DRUG
6.3.1 INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
6.3.2 BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
6.4.1 SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
7 U.S. PSYCHEDELIC DRUGS MARKET, BY SOURCE
8 U.S. PSYCHEDELIC DRUGS MARKET, BY TYPE
8.4 SEROTONERGIC (CLASSICAL PSYCHEDELIC DRUGS)
9 U.S. PSYCHEDELIC DRUGS MARKET, BY APPLICATION
9.3 TREATMENT- RESISTANT DEPRESSION (TRD)
9.4 POST-TRAUMATIC STRESS DISORDER (PTSD)
9.5 MAJOR DEPRESSIVE DISORDER
10 U.S. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION
11 U.S. PSYCHEDELIC DRUGS MARKET, BY DRUGS
11.2 GAMMA-HYDROXYBUTYRIC ACID (GHB)
11.4 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)
12 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER
12.3 SPECIALTY CLINICS
12.4 RESEARCH ORGANISATION
13 U.S. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
13.2 HOSPITAL PHARMACY
13.3 COMPOUNDING PHARMACY
14 U.S. PSYCHEDELIC DRUGS MARKET, COMPANY LANDSCAPE
15 COMPANY PROFILE
15.1 JAZZ PHARMACEUTICALS, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 PIPELINE PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 JOHNSON & JOHNSON SERVICES, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
16 POTENTIAL PLAYERS PROFILE
16.1 AVADEL PHARMACEUTICALS, PLC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PIPELINE PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 AMNEAL PHARMACEUTICALS LLC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PIPELINE PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 CELON PHARMA SA
16.3.1 COMPANY SNAPSHOT
16.3.2 PIPELINE PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4.1 COMPANY SNAPSHOT
16.4.2 PIPELINE PORTFOLIO
16.4.3 RECENT DEVELOPMENTS
16.5 DEVELCO PHARMA SCHWEIZ AG
16.5.1 COMPANY SNAPSHOT
16.5.2 PIPELINE PORTFOLIO
16.5.3 RECENT DEVELOPMENT
16.6 DOUGHLAS PHARMACEUTICALS LIMITED
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 HIKMA PHARMACEUTICALS PLC
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 NEURORX, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9.1 INSTITUTE SNAPSHOT
16.9.2 PIPELINE PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
18 RELATED REPORT
Region & Countries (Customizable):
- North America (Canada, United States & Mexico)
- Europe (Germany, the United Kingdom, Benelux, France, Russia & Italy)
- Asia-Pacific (Japan, South Korea, China, India & Southeast Asia)
- South America (Argentina, Brazil, Peru, Colombia, Etc.)
- Middle East & Africa (United Arab Emirates, Egypt, Saudi Arabia, Nigeria & South Africa)
More Information Related to TOC, Tables, and Figures Can Be Provided
- No. of Microalgae Market Report Pages: 350
- No of Tables: 220
- No of Figures: 60
Coronavirus can influence the worldwide economy in three principal ways: by straightforwardly influencing creation and request, by making store network and market disturbance, and by its monetary effect on firms and monetary business sectors. The episode of COVID-19 has welcomed impacts on numerous viewpoints, similar to flight undoings travel boycotts and isolates cafés shut all indoor occasions confined more than forty nations highly sensitive situation proclaimed monstrous easing back of the Vaccine market unpredictability falling business certainty, developing frenzy among the populace, and vulnerability about future.
Covid-19 Impact Analysis@ https://www.databridgemarketresearch.com/covid-19-impact/us-psychedelic-drugs-market
U.S. Psychedelic Drugs Market Scope and Market Size
U.S. psychedelic drugs market is segmented on the basis of source, type, application, route of administration, drugs, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of source, the market is segmented into synthetic and natural. Synthetic dominates the psychedelic drugs market as all available drugs are derived from synthetic origin. For this reason, the synthetic segment dominates the market and will also grow at a higher rate over the forecasted period.
U.S. Psychedelic Drugs Market, By Source
- On the basis of type, the market is segmented into dissociatives, empathogens, and serotonergic (classical psychedelic drugs). The dissociatives segment dominates the psychedelic drugs market as XYREM (sodium oxybate, Jazz Pharmaceuticals Inc.) is the only approved drug of disruptive psychedelics for the treatment of narcolepsy.
- On the basis of application, the market is segmented into narcolepsy, treatment-resistant depression, post-traumatic stress disorder (PTSD), major depressive disorder, others. Narcolepsy as a gamma hydroxybutyric acid (GHB) derivative dominates the psychedelic drugs market and primarily uses psychedelic medicine and the drug has been approved for narcolepsy. Due to this reason, the narcolepsy segment dominates the psychedelic drugs market.
- On the basis of route of administration, the market is segmented into oral, intranasal, parenteral, others. Oral is dominant in the psychedelic drugs market as Xyrem is the most branded drug available in the market in oral dosage forms. In addition, patient adherence is very important in symptomatic treatment of the disease. Oral administration of the drug is highly convenient for patients as compared to other forms.
- On the basis of drugs, the market is segmented into gamma hydroxybutyric acid (GHB), ketamine, 3,4-methylenedioxymethamphetamine (ecstasy), psilocybin. Gamma hydroxybutyric acid (GHB) dominates the psychedelic drugs market as Xyrem is primarily psychedelic drug and falls into this category. For this reason, the gamma hydroxybutyric acid (GHB) segment dominates the psychedelic drugs market.
- On the basis of end user, the market is segmented into hospitals, speciality clinic, research organisation, others. Hospitals dominate the psychedelic drugs market due to high patient load and most medicines are given under the supervision of a doctor. For this reason, the hospital segment dominates the psychedelic drugs market.
- On the basis of distribution channel, the market is segmented into hospital pharmacy, compounding pharmacy, others. Hospital pharmacy has the largest market share as these medicines treat more number of patients in hospitals, demand for medicines increases in hospital pharmacy.
U.S. Psychedelic Drugs Market, Country Level Analysis
The U.S. psychedelic drugs market is analysed and market size information is provided by source, type, application, route of administration, drugs, end user and distribution channel as referenced above.
Growing acceptance of psychedelic drugs for treating depression across the U.S. is one of the prominent factors for an upsurge demand of psychedelic drugs. Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway named has stated that in the U.S., more than 30 million people are using psychedelic drugs. This factor has increased the research and development activities in psychedelic drugs across the U.S. Hence, this factor has led various pharmaceutical and therapeutic manufactures to shift towards psychedelic drugs. This has further resulted into continuous focus of psychedelic drugs improvement and reduction of side effects associated with psychedelic drugs. Due to these factors, the market is expected to grow at the significant growth rate in the forecast period of 2020 to 2027.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing R&D Activities in Psychedelic Drugs is Creating New Opportunities for Manufacturers in the U.S. Psychedelic Drugs Market
U.S. psychedelic drugs market also provides you with detailed market analysis for every country growth in aesthetic industry with psychedelic drugs sales, impact of advancement in the psychedelic drugs and changes in regulatory scenarios with their support for the psychedelic drugs market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Psychedelic Drugs Market Share Analysis
U.S. psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the U.S. psychedelic drugs market.
Advantages of Buying the Report:
Our report is additionally known for its information exactness and granular market investigation
A total image of the serious situation of the at-home testing units market is portrayed by this report.
The broad range of investigation in regards to the significant headways
It likewise gives a total evaluation of things to come market and the changing business sector situation.
Study the market techniques that are being received by your rivals and driving associations.
Key Points Covered in Table of Content:
The report is essentially fragmented into a few key locales, import, fare, income, and piece of the pie and development pace of Microalgae in these areas, from 2021 to 2028, covering:
Presentation: It incorporates the goals and extent of the examination and gives features of key market fragments and players covered.
Leader Summary: It covers industry patterns with high spend significant time in market use cases and top market patterns, piece of the pie by locales, and Microalgae Market size and development by areas.
Central members: Here, the report centers around consolidations and acquisitions, developments, examination of vital participants, establishment date of organizations, and territories served, detailing base, and income of vital participants.
Breakdown by Market Segmentation: This segment gives insights regarding market size by item and application.
Worldwide Microalgae Market, By Geography Analysis: All of the areas and nations examined inside the report are concentrated on market size by item and application, central members, and market figure.
Profiles of International Players: Here, players are assessed on the possibility of their edge of benefit, value, deals, income, business, items, and other organization subtleties.
Market Dynamics: It incorporates store network examination, investigation of territorial promoting, difficulties, openings, and drivers dissected inside the report.
The study of disease transmission of the Research Study
Informative supplement: It incorporates insights concerning examination and philosophy approach, research strategy, information sources, creators of the investigation, and a disclaimer.
Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Top Trending Reports:
Global Psychedelic Drugs Market Growth With Worldwide Industry Analysis To 2027 Drugs-Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin | Players-Celon Pharma S.A. COMPASS F. Hoffmann-La Roche Ltd Hikma Pharmaceuticals PLC NeuroRx, Inc. PharmaTher Inc
Global Physical Therapy Market Is Rising Exponentially At A CAGR Of 6.15% In The Forecast Period Of 2020 To 2027 ||Application- Orthopedic Physical Therapy, Geriatric Physical Therapy And Neurological Physical Therapy
U.S. Psychedelic Drugs Market Is Expected To Reach USD 6,859.95 Million By 2028 || Growth, Share, Demand And Analysis Of Key Players-Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma
Why Go For Data Bridge Market Research?
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered to more than 40% of the fortune 500 companies ly and have a network of more than 5000+ clientele around the globe. Our coverage of industries includes: HEALTHCARE
FOOD & BEVERAGE
CHEMICAL & MATERIALS
SEMICONDUCTORS AND ELECTRONICS
MATERIALS & PACKAGING
AGRICULTURE & ANIMAL FEED
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
- The Wire Times